Indian Generics in the USA / Destined for More Success?
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
GVK Bio India
Last updated: 02.02.2018
GVK BIO, a leading Contract Research & Development Organization – CRDO that services the global Biopharma industry; is headquartered in Hyderabad, India with operations in four sites including California, USA. Established in 2001, GVK BIO has over 16 years of rich experience across the Research and Development value chain with a focus on speed and quality. Our team of over 2000 highly qualified scientists, backed by well-defined and scalable processes, modern facilities and a strong customer-centric partnering approach, focus on bringing our customers’ products to market. We partner with reputed global academic institutions and research laboratories to find efficient, cost-effective and innovative solutions to their Research and Development challenges.
Contact:
Address: GVK Biosciences Private Limited, Plot No. 28 A, IDA Nacharam, Hyderabad –500076, India
Website: http://www.gvkbio.com
Email: corpcomm@gvkbio.com
Related
Coronavirus / Indian Pharma Supply Chain Hit by Covid-19 Outbreak
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
News Roundup / Indian Pharma: January 2020
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the…
India / Biocon's New Facility & Expansion in APAC
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with…
Gujarat / The Home of Indian Pharma
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the…
Pharma Faces / Vivek Sharma, PPS
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the…
China: Indian Pharma Firms Incoming
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports…
India Healthcare: “Modicare” Lives On
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…
India’s Drug Regulatory Reforms: Building Trust
Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more…
10 Pharma Leaders to Know in India
Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe,…
Africa: The Launchpad for Indian Pharma
Although most industry observers expect that Indian pharma exports to the US will pick up again in the coming…
Meeting US FDA Standards Across the Board in India
In a context where even well-established, multi-billion-dollar domestic companies have received warning letters…
